Our findings of downregulation of p53 and p16, as well as increased elastin content, in vaginal tissue of Fbln-5-/- mice receiving D+Q injections demonstrate the potential for senolytic agents to target early changes associated with cellular senescence, which may ultimately contribute to the development of pelvic organ prolapse. This evidence concerns the gene TP53 and pelvic organ prolapse.